Annotation Detail for SCN5A
Basic Information
TopGene Symbol: | SCN5A ( CDCD2,CMD1E,CMPD2,HB1,HB2,HBBD,HH1,ICCD,IVF,LQT3,Nav1.5,PFHB1,SSS1,VF1 ) |
---|
Gene Full Name: | sodium channel, voltage-gated, type V, alpha subunit |
---|
Band: | 3p22.2 |
---|
Quick Links | Entrez ID:6331; OMIM: 600163; Uniprot ID:SCN5A_HUMAN; ENSEMBL ID: ENSG00000183873; HGNC ID: 10593 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
| Axon guidance |
Desease ID | Desease Name |
---|
1787 | Heart disease |
1832 | Congenital abnormality |
1866 | Sudden infant death syndrome |
1870 | Drug abuse |
1878 | Ischemia |
1911 | Intestinal disease |
1944 | Breast cancer |
2092 | Long QT syndrome |
Desease Name |
---|
Electrocardiographic conduction measures |
early onset of sudden infant death. |
Atrial Fibrillation |
CARDIOVASCULAR |
SIDS/sudden infant death syndrome |
QT interval |
Drug-induced long-QT syndrome |
inherited cardiac arrhythmia long QT syndrome |
cardiac arrhythmias and sudden death |
Brugada syndrome |
cardiac conduction disturbances and degenerative changes |
Desease Name |
---|
Electrocardiographic traits |
PR interval |
Electrocardiographic conduction measures |
QT interval |
Desease Name |
---|
Long QT syndrome-3 |
Brugada syndrome 1 |
Heart block, nonprogressive |
Cardiomyopathy, dilated, 1E |
Sick sinus syndrome 1 |
Heart block, progressive, type IA |
Ventricular fibrillation, familial, 1 |
Sudden infant death syndrome, susceptibility to |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C520323 |
1-oleoyl-2-acetoyl-sn-glycerol |
1-oleoyl-2-acetoyl-sn-glycerol results in decreased activity of SCN5A protein | decreases activity | 12796143
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of SCN5A mRNA | decreases expression | 15520326
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SCN5A mRNA | affects expression | 16483693
|
D001977 |
Brompheniramine |
Brompheniramine results in decreased activity of SCN5A protein | decreases activity | 17010640
|
D007545 |
Isoproterenol |
Isoproterenol results in increased expression of SCN5A mRNA | increases expression | 17526999
|
D009543 |
Nifedipine |
Nifedipine results in decreased activity of SCN5A protein | decreases activity | 17978865 16331678
|
D012964 |
Sodium |
SCN5A protein affects the transport of Sodium | affects transport | 17065252
|
D013779 |
Tetrodotoxin |
Tetrodotoxin results in decreased activity of SCN5A protein | decreases activity | 17978865
|
D015032 |
Zinc |
Zinc results in decreased activity of SCN5A protein | decreases activity | 16410023
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.69 | 17202136 16889938 17190629 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.79 | 17119284 16580781 16325427 16410023 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
5.14 | 16916123 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.99 | 18057881 20041841 18218290 |
MESH:D001249 |
Asthma |
|
Zinc |
3.00 | 17085522 |
MESH:D001281 |
Atrial Fibrillation |
marker/mechanism |
|
| 20062060 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
4.05 | 19698954 18651412 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
4.11 | 19483382 |
MESH:D001919 |
Bradycardia |
|
Isoproterenol |
5.47 | 6740701 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.95 | 17109824 |
MESH:D053840 |
Brugada Syndrome |
marker/mechanism |
|
| |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
2.95 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Isoproterenol |
4.27 | 11179087 7544033 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.95 | 19225199 15710769 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.79 | 16936243 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.37 | 18974383 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.44 | 19302082 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.39 | 16479319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
2.44 | 18218290 15265979 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
2.90 | 16543248 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
3.72 | 14986274 |
MESH:D005756 |
Gastritis |
|
Zinc |
5.11 | 17241300 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
4.08 | 17217573 |
MESH:D006333 |
Heart Failure |
|
Isoproterenol |
8.17 | 18097624 |
MESH:D006333 |
Heart Failure |
|
Zinc |
8.17 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
6.09 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.75 | 17241300 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.95 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
4.01 | 15265979 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
4.08 | 9751232 8137927 |
MESH:D006973 |
Hypertension |
|
Nifedipine |
4.30 | 20102058 |
MESH:D006984 |
Hypertrophy |
|
Isoproterenol |
5.40 | 12791704 |
MESH:D007022 |
Hypotension |
|
Isoproterenol |
5.01 | 6740701 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.77 | 18020914 17991464 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.89 | 16584753 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
3.43 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.63 | 16518626 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.65 | 15342952 17567588 |
MESH:D008133 |
Long QT Syndrome |
marker/mechanism |
|
| 10627139 12796143 17110414 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.73 | 15350150 11989578 17391786 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.50 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.80 | 18516814 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
3.42 | 12773700 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
5.22 | 12754197 17974566 |
MESH:D009203 |
Myocardial Infarction |
|
Isoproterenol |
3.92 | 17052832 19172585 19595682 16697266 16584858 16538859 15740881 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.33 | 17114810 |
OMIM:113900 |
PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA |
marker/mechanism |
|
| |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.79 | 16700911 12429649 16517595 16606632 |
MESH:D011654 |
Pulmonary Edema |
|
Isoproterenol |
5.57 | 10903255 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.92 | 12490602 11597910 12832656 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.28 | 16584753 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.37 | 18724381 |
OMIM:608567 |
SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE |
marker/mechanism |
|
| |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
8.64 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Nifedipine |
8.64 | 14653237 |
MESH:D013398 |
Sudden Infant Death |
marker/mechanism |
|
| |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.53 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.43 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
5.08 | 19731979 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
5.12 | 18020914 19584973 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.59 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.47 | 11989578 17467628 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Isoproterenol |
5.38 | 18097624 |
OMIM:603829 |
VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1 |
marker/mechanism |
|
| |
MESH:D020257 |
Ventricular Remodeling |
|
Isoproterenol |
5.97 | 18097624 |
PharmGKB Accession:PA304
Releated gene ID |
Related gene Name |
PA304 | SCN5A |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00192 |
blocker |
Indecainide |
Antidysrhythmic Agents;Sodium channel blockers |
DB00243 |
antagonist |
Ranolazine |
Enzyme Inhibitors |
DB00252 |
antagonist |
Dilantin W Phenobarbital 30mg Cap |
Anticonvulsants |
DB00280 |
antagonist |
Disopyramide |
Antiarrhythmic Agents;Anti-Arrhythmia Agents |
DB00281 |
antagonist |
Xylonor Spray |
Antiarrhythmic Agents;Anesthetics;Anesthetics, Local;Anti-Arrhythmia Agents |
DB00379 |
antagonist |
Mexiletine |
Anti-Arrhythmia Agents |
DB00473 |
antagonist |
Hexylcaine |
Anesthetics;Local Anesthetics |
DB00527 |
antagonist |
Sandoz Proctomyxin Hc |
Anesthetics, Local |
DB00532 |
antagonist |
Mephenytoin |
Anticonvulsants |
DB00564 |
antagonist |
Carbamazepine |
Anticonvulsants;Analgesics;Antimanic Agents;Analgesics, Non-Narcotic |
DB00661 |
other |
Tarka |
Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Anti-Arrhythmia Agents |
DB00680 |
blocker |
Moricizine |
Anti-Arrhythmia Agents |
DB00740 |
antagonist |
Riluzole |
Anticonvulsants;Neuroprotective Agents;Anesthetics;Excitatory Amino Acid Antagonists |
DB00750 |
blocker |
Prilocaine |
Anesthetics;Local Anesthetics;Anesthetics, Local |
DB00754 |
blocker |
Ethotoin |
Anticonvulsants |
DB00776 |
antagonist |
Oxcarbazepine |
Anticonvulsants |
DB00868 |
blocker |
Benzonatate |
Antitussives |
DB00907 |
blocker |
Cocaine |
Vasoconstrictor Agents;Dopamine Uptake Inhibitors;Anesthetics;Local Anesthetics;Anesthetics, Local |
DB00908 |
blocker |
Quinidine |
Enzyme Inhibitors;Antiarrhythmic Agents;Antimalarials;Muscarinic Antagonists;Adrenergic alpha-Antagonists;Anti-Arrhythmia Agents |
DB00909 |
antagonist |
Zonisamide |
Antioxidants;Anticonvulsants |
DB01035 |
blocker |
Procainamide |
Antiarrhythmic Agents;Anti-Arrhythmia Agents |
DB01056 |
antagonist |
Tocainide |
Sodium channel blockers;Anti-Arrhythmia Agents |
DB01182 |
antagonist |
Propafenone |
Anti-Arrhythmia Agents |
DB01195 |
blocker |
Flecainide |
Antiarrhythmic Agents;Anti-Arrhythmia Agents |
DB01228 |
blocker |
Encainide |
Sodium channel blockers;Antiarrhythmic Agents;Anti-Arrhythmia Agents |
DB01320 |
antagonist |
Fosphenytoin |
Anticonvulsants |
DB01346 |
antagonist |
Quinidine barbiturate |
|
DB01426 |
antagonist |
Ajmaline |
Antiarrhythmic Agents;Anti-Arrhythmia Agents |
DB01429 |
antagonist |
Aprindine |
Anti-Arrhythmia Agents |